eCAM Advance Access originally published online on February 9, 2005
eCAM 2005 2(1):1-3; doi:10.1093/ecam/neh062
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author (2005). Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
Editorial |
Bioprospecting: a CAM Frontier
Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90095-1763, USA. Tel: 310-825-9567, Fax: 310-825-2224 Email: ecam@mediet.ucla.edu
| The first 10% of the full text of this article appears below. |
 |
What is Bioprospecting in Relation to CAM? |
|---|
With Volume 2 of eCAM, we begin to intensify the inclusion of complementary and alternative medicine (CAM)-related natural products derived from plants and from animals (1). There will be an attempt to focus on products from animals, since we know that the literature tends to be ‘glutted’ with products derived from plants (1,2). In either case, both sources of natural products provide a veritable cornucopia of sources of new CAM approaches that will emerge as important for future applications, including compounds isolated from marine microorganisms and phytoplankton, green algae, brown algae, red algae, fungi and certain well-known marine and terrestrial animals: sponges, coelenterates, bryozoans, molluscs, tunicates, echinoderms, earthworms and leeches (3,4). Very briefly, there has been an emphasis on new compounds (677 in 2002), together with their relevant biological activities, source organisms and country of origin.
|
Organismic Benefits of Bioprospecting |
|---|
|
Effective Compounds from a Pivotal Marine Group: the Sponge as Paradigm |
|---|
|
Philosophical Underpinning: a Cautionary Note |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Liu, Y. Fukuwatari, K. Okumura, K. Takeda, K.-i. Ishibashi, M. Furukawa, N. Ohno, K. Mori, M. Gao, and M. Motoi Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 205 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hielm-Bjorkman, R.-M. Tulamo, H. Salonen, and M. Raekallio Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus) Evid. Based Complement. Altern. Med., October 29, 2007; (2007) nem136v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Lee, J. H.-K. Lum, C. K.-C. Ng, J. McKay, Y. K.-C. Butt, M.-S. Wong, and S. C.-L. Lo Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model Evid. Based Complement. Altern. Med., September 26, 2007; (2007) nem100v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper Colony Collapse Disorder May Affect Complementary and Alternative Medicine Evid. Based Complement. Altern. Med., September 1, 2007; 4(3): 275 - 277. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Olalde Rangel, M. Magarici, F. Amendola, and O. del Castillo The Systemic Theory of Living Systems. Part IV: Systemic Medicine--The Praxis Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 429 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper ECAM is waiting for eCAM Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 427 - 428. [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper The Amazing Science Behind Nature's 'Miracle From The Sea' Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 569 - 570. [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper eCAM benefits from diversity that derives from CAM Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265. [Full Text] [PDF]
|
|
E-letters:
Read all E-letters
- Validating CAM therapies.
- Pradeep G Paul
- Evidence-based Complementary and Alternative Medicine, 14 Apr 2005 [Full text]